Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac suppository plus intramuscular hyoscine-N-butylbromide versus intramuscular hyoscine-N-butylbromide alone for pain relief during hysterosalpingography
PACTR202411693623624Recruiting
- Sponsor
- DR IFEANYI KINGSLEY NWAEJU
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of diclofenac and hyoscine butylbromide (2 arms), sponsored by DR IFEANYI KINGSLEY NWAEJU. Primary endpoint: Mean pain scores at different stages of the procedure and 30 minutes after the procedure. Started May 2024; status: recruiting.
02
Drugs
diclofenachyoscine butylbromide
Beyond the preview
Go deeper on PACTR202411693623624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202411693623624.